Wanrudee IsaranuwatchaiYot TeerawattananonRachel A. ArcherAlia LuzManushi SharmaWaranya RattanavipapongThunyarat AnothaisintaweeRachel L. BaconTazeem BhatiaJesse BumpKalipso ChalkidouAdam G. ElshaugDavid D. KimSumithra Krishnamurthy ReddiarRyota NakamuraPeter J. NeumannArisa ShichijoPeter C. SmithAnthony J. CulyerImperial College Business SchoolPublic Health EnglandNational Health Foundation, ThailandHarvard T.H. Chan School of Public HealthThe University of SydneyBoston UniversityNational University of SingaporeSaint Michael's Hospital University of TorontoUniversity of TorontoUniversity of YorkFaculty of Medicine, Ramathibodi Hospital, Mahidol UniversityTufts University School of MedicineImperial College LondonHitotsubashi UniversityThe Brookings InstitutionTufts Medical CenterCentre for Global DevelopmentHealth Intervention and Technology Assessment Program (HITAP)2020-03-262020-03-262020-01-01The BMJ. Vol.368, (2020)17561833095981462-s2.0-85078688002https://repository.li.mahidol.ac.th/handle/20.500.14594/53883Mahidol UniversityMedicinePrevention of non-communicable disease: Best buys, wasted buys, and contestable buysArticleSCOPUS10.1136/bmj.m141